AstraZeneca
AZN
#70
Rank
A$353.84 B
Marketcap
A$228.15
Share price
-0.84%
Change (1 day)
-12.71%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): A$9.85

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$9.60. In 2024 the company made an earnings per share (EPS) of A$6.52 an increase over its 2023 EPS that were of A$5.52.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$9.85
2024A$6.5218.23%
2023A$5.5281.13%
2022A$3.05631.03%
2021A$0.42-88.11%
2020A$3.51136.89%
2019A$1.48-39.41%
2018A$2.44-28.27%
2017A$3.41-14.37%
2016A$3.9824.11%
2015A$3.20127.55%
2014A$1.41-51.96%
2013A$2.93-58.95%
2012A$7.14-32.2%
2011A$10.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.55 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.57-0.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.09-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.48-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.94 347.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.73-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$8.16-14.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.82-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.52-32.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.59-52.13%๐Ÿ‡ฌ๐Ÿ‡ง UK